Clinical trial Recruiting at 1 site Interventional Women only

Early transfer of culture medium before embryo transfer

Official title: Advantages of Early Intrauterine Transfer of "Blank" Culture Medium Prior to 1st or 2nd Transfer of Thawed Embryo(s). Randomized, Single-blind, Multicenter Controlled Trial.

Run by Centre Hospitalier Universitaire de Nīmes · NCT06177613 · Data updated 2026-11-12

This study is testing if putting a special fluid in the uterus before transferring frozen embryos can help women who have had trouble getting pregnant in the past.

Quick facts

Study typeInterventional
SexWomen only
Enrollment1154 (estimated)
SponsorCentre Hospitalier Universitaire de Nīmes
Academic / other
Locations7 sites (Clamart and 6 other locations)
StatusRecruiting
StartedFebruary 9, 2024
Main results expectedMay 2026
Study endsFebruary 2027
Registry record updatedFebruary 20, 2025
Trial IDNCT06177613 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women who have experienced a failed embryo transfer and have frozen embryos available for transfer.

Probably not a fit

Patients who have not experienced a previous embryo transfer failure or those with embryos not at the D3 stage may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the benefits of transferring a 'blank' culture medium into the uterus before the transfer of thawed embryos in patients who have previously experienced implantation failure. The aim is to enhance the communication between the embryo and the uterine lining, potentially improving the chances of successful implantation. The study will involve patients who have undergone a prior embryo transfer that did not result in pregnancy, focusing on those with frozen embryos at the D3 stage. Participants will be randomly assigned to receive either the culture medium transfer or a sham transfer.

Why it matters

Potential benefit: If successful, this approach could significantly improve pregnancy rates for patients undergoing single embryo transfers.

How similar studies have gone: While there have been studies on sequential embryo transfers, the specific approach of early culture medium transfer is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Having had a first "fresh" or frozen embryo transfer, whatever the embryo's stage of development, transfer followed by pregnancy failure ;
* Frozen embryos must be at least D3 stage;
* The patient must have given their free and informed consent and signed the consent form
* The patient must be a member or beneficiary of a health insurance plan

Exclusion Criteria:

* The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
* The patient is under safeguard of justice or state guardianship

Where it's running

  • CHU de Nîmes
    Nîmes, France
    Recruiting
  • Hôpital Antoine Béclère
    Clamart, France
    Not yet recruiting
  • Centre Hospitalier Alpes Léman
    Contamine-sur-Arve, France
    Not yet recruiting
  • CHU Arnaud de Villeneuve
    Montpellier, France
    Not yet recruiting
  • Clinique Saint Roch
    Montpellier, France
    Not yet recruiting
  • Clinique Saint-Pierre
    Perpignan, France
    Not yet recruiting
Show 1 more location
  • CHU de la Réunion
    Saint-Pierre, Reunion
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.